This statistic shows the total equity of the French pharmaceutical group Ipsen from 2014 to 2019 in million euros. The group's total equity reached 1.75 billion euros in 2019. Comparatively, the total equity of Ipsen was valued 1.06 and 1.2 billion euros in 2014 and 2015. On another note, Ipsen had more than 4.3 billion euros of assets in 2019.
Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
10
- Premium Statistic Total liabilities of the Ipsen group 2014-2019
- Premium Statistic Total assets of the Ipsen group 2014-2019
- Premium Statistic Commercial expenses of the Ipsen group 2014-2019
- Premium Statistic Research and development expenditure of the Ipsen group 2014-2019
- Premium Statistic Operating profit of the Ipsen group 2014-2019
- Premium Statistic Consolidated net profit of the Ipsen group 2014-2019
- Premium Statistic Global revenue in general medicine of the Ipsen group 2014-2019
- Basic Statistic Orphan drug sales worldwide by therapy category 2028
- Basic Statistic Orphan vs. non-orphan pipeline sales forecast worldwide 2023-2028
- Premium Statistic Global revenue of the Ipsen group 2019, by geographical area
About the region
9
- Premium Statistic Global revenue in specialty medicine of the Ipsen group 2014-2019
- Premium Statistic Orphan vs. non-orphan drugs median cost per patient per year 2014-2018
- Basic Statistic Members of EFPIA's pharmaceutical exports and imports 1990-2022
- Premium Statistic Top global companies by orphan drug revenues 2023
- Premium Statistic Merck & Co.'s top-selling drugs 2023
- Basic Statistic Top drugs based on projected 2024 global sales
- Basic Statistic Worldwide Rx drug sales excluding generics and orphan drugs 2012-2026
- Premium Statistic Global revenue of the Ipsen group 2014-2019
- Basic Statistic Medication sales of the Ipsen Group 2019
Selected statistics
4
Other regions
10
- Basic Statistic Top U.S. oncology products by revenue in 2016
- Premium Statistic Revenue from pharmaceutical manufacturer in Denmark 2009-2023
- Premium Statistic Members of EFPIA's pharmaceutical R&D spending 1990-2022
- Premium Statistic Market share of Celltrion's Remsima in Europe Q1 2015-Q2 2018
- Premium Statistic Italy: number of R&D employees of biotech pharma companies 2014-2017
- Premium Statistic Pharma market value in Colombia 2008-2021
- Premium Statistic Pharma market value in Argentina 2008-2021
- Basic Statistic Leading pharmaceutical companies in Norway 2021, by revenue
- Premium Statistic Sold packaging units of phytopharmaceuticals in Germany in 2022, by sales channel
- Premium Statistic Venezuela: pharma industry market value 2008-2017
Related statistics
10
- Premium Statistic Revenue of the top ten pharmaceutical companies in France 2021
- Basic Statistic Number of employees of pharmaceutical companies by region France 2020
- Basic Statistic Total revenue of the French drug market worldwide 2010-2018
- Premium Statistic Chemical peel facial rejuvenation market size worldwide from 2016-2026
- Basic Statistic Breakdown of employees of drug companies by age France 2014
- Basic Statistic Average cost of hospital per day by country 2015
- Premium Statistic Boiron laboratories' European turnover in 2022, by country
- Premium Statistic Turnover of Boiron laboratories abroad 2012-2022
- Premium Statistic Turnover of Boiron laboratories in North America 2022, by country
- Premium Statistic EBITDA of Boiron laboratories 2012-2022
Further related statistics
9
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
Further Content: You might find this interesting as well
Statistics
- Merck & Co total assets 2009-2023
- Merck & Co - expenditure on research and development 2006-2023
- M&A capacities - changes for the global pharma industry 2008-2015
- Celgene's revenue and net income 2006-2018
- Sanofi's total assets 2007-2023
- Pfizer's ad spending 2006-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Revenue of Sinopharm 2011-2022, by category
Ipsen. (February 13, 2020). Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph]. In Statista. Retrieved May 23, 2024, from https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen. "Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros)." Chart. February 13, 2020. Statista. Accessed May 23, 2024. https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen. (2020). Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros). Statista. Statista Inc.. Accessed: May 23, 2024. https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen. "Total Equity of The French Pharmaceutical Group Ipsen from 2014 to 2019 (in Million Euros)." Statista, Statista Inc., 13 Feb 2020, https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/
Ipsen, Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) Statista, https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/ (last visited May 23, 2024)
Total equity of the French pharmaceutical group Ipsen from 2014 to 2019 (in million euros) [Graph], Ipsen, February 13, 2020. [Online]. Available: https://www.statista.com/statistics/1073015/ipsen-total-equity-french-company/